CNSY
Cerenome, Inc.
There isn't enough reported data to score CNSY yet.
CNSY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Weak | |
| Unavailable |
CNSY's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.
CNSY PE Valuation
CNSY has no meaningful PE right now: it lost money over the past year.
CNSY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CNSY's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CNSY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$69.50 | +$51.75 |
| Q4 2024 | -$58.50 | +$96.50 |
| Q3 2024 | -$108.50 | +$40.00 |
| Q2 2024 | -$124.25 | +$70.50 |
| Q1 2024 | -$121.25 | +$148.75 |
| Q4 2023 | -$155.00 | +$133.75 |
| Q3 2023 | -$148.50 | +$177.75 |
| Q2 2023 | -$194.75 | +$165.25 |
CNSY is still losing money, but far less than before: $69.50 per share over the past year, against $716.25 at its worst in early 2021.
CNSY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $411K | -70% |
| Q1 2026 | $1M | -2.9% |
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2204% | -2093 points |
| Q1 2026 | -693% | -359 points |
| Q4 2025 | -420% | N/A |
| Q3 2025 | -321% | N/A |
| Q2 2025 | -111% | N/A |
| Q1 2025 | -334% | N/A |
CNSY's operating margin was −2204% last quarter, down 2093 points from the same quarter a year ago, near the bottom of its range since 2025.
CNSY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$7.6M | -$1.8M |
| Q1 2026 | -$7.1M | -$881K |
| Q4 2025 | -$6.3M | -$5.1M |
| Q3 2025 | -$2.6M | +$1.1M |
| Q2 2025 | -$5.8M | -$4.6M |
| Q1 2025 | -$6.2M | -$1.6M |
| Q4 2024 | -$1.2M | +$659K |
| Q3 2024 | -$3.7M | -$1.3M |
CNSY has burned cash in almost every quarter: −$24M over the past year, against −$17M the year before.
CNSY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +89% | +275K shares |
| 1 year | +237% | +410K shares |
| 3 years | +1834% | +553K shares |
CNSY has 582,669 diluted shares, up 237% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $374,000 |
CNSY Net Leverage
CNSY's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CNSY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 6.0 | Oversold |
CNSY's weekly RSI is 26 (oversold) and its Stochastic is 6 (oversold).
CNSY PE vs Healthcare Sector
CNSY has no meaningful PE right now: it lost money over the past year.
CNSY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.50 | 49% below |
| 20 week MA | $2.61 | 70% below |
| 50 week MA | $5.70 | 86% below |
| 100 week MA | $11.8 | 93% below |
| 200 week MA | $35.8 | 98% below |
CNSY is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
CNSY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $922.5 | $836.3 | -9.3% |
| 2021 | $836.3 | $442.5 | -47% |
| 2022 | $442.5 | $116.3 | -74% |
| 2023 | $116.3 | $43.8 | -62% |
| 2024 | $43.8 | $29.0 | -34% |
| 2025 | $29.0 | $14.5 | -50% |
| 2026 YTD | $14.5 | $0.77 | -95% |
CNSY has finished every year since 2020 lower, and it's down 95% so far in 2026.